Dynamic Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Dynamic Capital Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,827	Closed	-$558K	–	52
2019 Q1	$558K	Buy	+1,827	New	+$493K	2.02%	16
2017 Q1	–	Sell	-7,394	Closed	-$1.35M	–	283
2016 Q4	$1.35M	Sell	7,394 -1,258	-15%	-$214K	0.14%	225
2016 Q3	$1.42M	Buy	8,652 +812	+10%	+$123K	0.18%	174
2016 Q2	$1.12M	Buy	7,840 +2,798	+55%	+$399K	0.13%	252
2016 Q1	$689K	Buy	5,042 +3,147	+166%	+$413K	0.26%	113
2015 Q4	$263K	Sell	1,895 -1,208	-39%	-$167K	0.13%	278
2015 Q3	$417K	Buy	+3,103	New	+$447K	0.11%	257

Other funds holding BIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

EIP

Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Dynamic Capital Management's BIO Position: Q2 2019 in Review

Dynamic Capital Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2019, closing a stake of 1,827 shares — an estimated $558K sold.

Dynamic Capital Management first reported a position in BIO in Q3 2015 and held it in 7 quarters. The position peaked at $1.42M in Q3 2016. 330 funds tracked by Wall St. Rank hold BIO as of Q2 2019.

Dynamic Capital Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2019 after selling out during the quarter.
Dynamic Capital Management sold 1,827 Bio-Rad Laboratories Class A shares in Q2 2019, an estimated $558K.
Dynamic Capital Management first reported a position in Bio-Rad Laboratories Class A in Q3 2015 and held it in 7 quarters.
Dynamic Capital Management's Bio-Rad Laboratories Class A position peaked at $1.42M in Q3 2016.
330 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2019.

Based on Dynamic Capital Management's 13F filing for Q2 2019, filed 12 Aug 2019.